Immune responses of infants to infection with respiratory viruses and live attenuated respiratory virus candidate vaccines

Vaccine

Volumn 16, Issue 14-15, 1998, Pages 1423-1432

  Crowe Jr , James E ^a  

^a VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Infant; Parainfluenza virus; Respiratory syncytial virus; Vaccines

Indexed keywords

INFLUENZA VACCINE; LIVE VACCINE; PARAINFLUENZA VIRUS 3 VACCINE; RESPIRATORY SYNCYTIAL VIRUS VACCINE; UNCLASSIFIED DRUG; VIRUS VACCINE;

ACTIVE IMMUNIZATION; ANTIBODY RESPONSE; CELLULAR IMMUNITY; CONFERENCE PAPER; GENETIC ANALYSIS; HUMAN; IMMUNE RESPONSE; INFANT; INTRANASAL DRUG ADMINISTRATION; NONHUMAN; PASSIVE IMMUNIZATION; PRIORITY JOURNAL; RESPIRATORY TRACT INFECTION; VACCINATION; VIRUS INFECTION;

CHILD; HUMANS; INFANT; INFANT, NEWBORN; INFLUENZA VACCINES; PARAINFLUENZA VIRUS 3, HUMAN; RESPIRATORY SYNCYTIAL VIRUS, HUMAN; RESPIRATORY TRACT INFECTIONS; VACCINES, ATTENUATED; VIRAL VACCINES;

EID: 0032147035     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0264-410X(98)00103-0     Document Type: Conference Paper

References (149)

1. 1 Fox, J.P., Hall, C.E., Cooney, M.K. and Foy, H.M. Influenza virus infections in Seattle families, 1975-1979. I. Study design, methods and the occurrence of infections by time and age. Am. J. Epidemiol. 1982, 116, 212-227.
2. 2 Glezen, W.P., Parades, A. and Taber, L.H. Influenza in children. Relationship to other respiratory agents. JAMA 1980, 243, 1345-1349.
3. 3 Glezen, P. and Denny, F.W. Epidemiology of acute lower respiratory disease in children. N. Engl. J. Med. 1973, 288, 498-505.
4. 4 Foy, H.M., Cooney, M.K., Maletzky, A.J. and Grayston, J.T. Incidence and etiology of pneumonia, croup and bronchiolotis in preschool children belonging to a prepaid medical care group over a four-year period. Am. J. Epidemiol. 1973, 97, 80-92.
5. 5 Monto, A.S. The Tecumseh study of respiratory illness. V. Patterns of infection with the parainfluenzaviruses. Am. J. Epidemiol. 1973, 97, 338-348.
6. 6 Kapikian, A.Z., Mitchell, R.H., Chanock, R.M., Shvedoff, R.A. and Stewart, C.E. An epidemiological study of altered clinical reactivity to respiratory syncytial (RS) virus infection in children previously vaccinated with an inactivated RS virus vaccine. Am. J. Epidemiol. 1969, 89, 405-421.
7. 7 Kim, H.W., Canchola, J.G. and Brandt, C.D. et al. Respiratory syncytial virus disease in infants despite prior administration of antigenic inactivated vaccine. Am. J. Epidemiol. 1969, 89, 422-434.
8. 8 Beem, M. Repeated infections with respiratory syncytial virus. J. Immunol. 1967, 98, 1115-1122.
9. 9 Henderson, F.W., Collier, A.M., Clyde, W.A. Jr. and Denny, F.W. Respiratory-syncytial-virus infection, reinfections and immunity. A prospective, longitudinal study in young children. N. Engl. J. Med. 1979, 300, 530-534.
10. 10 Hall, C.B., Walsh, E.E., Long, C.E. and Schnabel, K.C. Immunity to and frequency of reinfection with respiratory syncytial virus. J. Infect. Dis. 1991, 163, 693-698.
11. 11 Wright, P.F., Mills, J. and Chanock, R.M. Evaluation of a temperature-sensitive mutant of respiratory syncytial virus in adults. J. Infect. Dis. 1971, 124, 505-511.
12. 12 Mills, J., Van Kirk, J.E., Wright, P.F. and Chanock, R.M. Experimental respiratory syncytial virus infection of adults. Possible mechanisms of resistance to infection and illness. J. Immunol. 1971, 107, 123-130.
13. 13 Wright, P.F., Belshe, R.B., Kim, H.W., Van Voris, L.P. and Chanock, R.M. Administration of a highly attenuated, live respiratory syncytial virus vaccine to adults and children. Infect. Immun. 1982, 37, 397-400.
14. 14 Kim, H.W., Arrobio, J.O. and Brandt, C.D. et al. Safety and antigenicity of temperature sensitive (TS) mutant respiratory syncytial virus (RSV) in infants and children. Pediatrics 1973, 52, 56-63.
15. 15 Clements, M.L., Belshe, R.B. and King, J. et al. Evaluation of bovine, cold-adapted human, and wild-type human parainfluenza type 3 viruses in adult volunteers and in chimpanzees. J. Clin. Microbiol. 1991, 29, 1175-1182.
16. 16 Karron, R.A., Wright, P.F., Crowe, J.E. Jr., et al. Evaluation of two live cold-passaged, temperature-sensitive respiratory syncytial virus (RSV) vaccines in chimpanzees, adults, children and infants. J. Infect. Dis. 1997, 176, 1428-1436.
17. 17 Friedewald, W.T., Forsyth, B.R., Smith, C.B., Gharpure, M.A. and Chanock, R.M. Low-temperature-grown RS virus in adult volunteers. JAMA 1968, 203, 690-694.
18. 18 Kim, H.W., Arrobio, J.O. and Pyles, G. et al. Clinical and immunological response of infants and children to administration of low-temperature adapted respiratory syncytial virus. Pediatrics 1971, 48, 745-755.
19. 19 Collins, P.L., McIntosh, K. and Chanock, R.M. Respiratory syncytial virus. In: Fields Virology (Eds Fields, B.N., Knipe, D.M. and Howley, P.M.). Lippincott-Raven Press, New York, 1996, pp. 1313-1351.
20. 20 Johnson, P.R. Jr., Olmsted, R.A. and Prince, G.A. et al. Antigenic relatedness between glycoproteins of human respiratory syncytial virus subgroups A and B: evaluation of the contributions of F and G glycoproteins to immunity. J. Virol. 1987, 61, 3163-3166.
21. 21 Hendry, R.M., Burns, J.C. and Walsh, E.E. et al. Strain-specific serum antibody responses in infants undergoing primary infection with respiratory syncytial virus. J. Infect. Dis. 1988, 157, 640-647.
22. 22 Muelenaer, P.M., Henderson, F.W. and Hemming, V.G. et al. Group-specific serum antibody responses in children with primary and recurrent respiratory syncytial virus infections. J. Infect. Dis. 1991, 164, 15-21.
23. 23 Fouillard, L., Mouthon, L. and Laport, J.P. et al. Severe respiratory syncytial virus pneumonia after autologous bone marrow transplantation: a report of three cases and review. Bone Marrow Transplant 1992, 9, 97-100.
24. 24 Harrington, R.D., Hooton, T.M. and Hackman, R.C. et al. An outbreak of respiratory syncytial virus in a bone marrow transplant center. J. Infect. Dis. 1992, 165, 987-993.
25. 25 Hall, C.B., Powell, K.R. and MacDonald, N.E. et al. Repiratory syncytial viral infection in children with compromised immune function. N. Engl. J. Med. 1986, 315, 77-81.
26. 26 Fishaut, M., Tubergen, D. and McIntosh, K. Cellular response to respiratory viruses with particular reference to children with disorders of cell-mediated immunity. J. Pediatr. 1980, 96, 179-186.
27. 27 Englund, J.A., Piedra, P.A., Jewell, A., Patel, K., Baxter, B.B. and Whimbey, E. Rapid diagnosis of respiratory syncytial virus infections in immunocompromised adults. J. Clin. Microbiol. 1996, 34, 1649-1653.
28. 28 Whimbey, E., Champlin, R.E. and Couch, R.B. et al. Community respiratory virus infections among hospitalized adult bone marrow transplant recipients. Clin. Inf. Dis. 1996, 22, 778-782.
29. 29 Whimbey, E., Couch, R.B. and Englund, J.A. et al. Respiratory syncytial virus pneumonia in hospitalized adult patients with leukemia. Clin. Inf. Dis. 1995, 21, 376-379.
30. 30 Englund, J.A., Sullivan, C.J., Jordan, M.C., Dehner, L.P., Vercellotti, G.M. and Balfour, H.H. Jr. Respiratory syncytial virus infection in immunocompromised adults. Ann. Intern. Med. 1988, 109, 203-208.
31. 31 Englund, J.A., Sullivan, C.J., Jordan, M.C., Dehner, L.P., Vercellotti, G.M. and Balfour, H.H. Jr. Respiratory syncytial virus infection in immunocompromised adults. Ann. Intern. Med. 1988, 109, 203-208.
32. 32 Yousuf, H.M., Englund, J. and Couch, R. et al. Influenza among hospitalized adults with leukemia. Clin. Inf. Dis. 1997, 24, 1095-1099.
33. 33 Garcia, R., Raad, I. and Abi-Said, D. et al. Nosocomial respiratory syncytial virus infections: prevention and control in bone marrow transplant patients. Infect. Control Hosp. Epidemiol. 1997, 18, 412-416.
34. 34 Whimbey, E., Elting, L.S. and Couch, R.B. et al. Influenza A virus infections among hospitalized adult bone marrow transplant recipients. Bone Marrow Transplant. 1994, 13, 437-440.
35. 35 Elting, L.S., Whimbey, E., Lo, W., Couch, R., Andreeff, M. and Bodey, G.P. Epidemiology of influenza A virus infection in patients with acute or chronic leukemia. Supportive Care in Cancer 1995, 3, 198-202.
36. 36 Lewis, V.A., Champlin, R. and Englund, J. et al. Respiratory disease due to parainfluenza virus in adult bone marrow transplant recipients. Clin. Inf. Dis. 1996, 23, 1033-1037.
37. 37 Whimbey, E., Vartivarian, S.E., Champlin, R.E., Elting, L.S., Luna, M. and Bodey, G.P. Parainfluenza virus infection in adult bone marrow transplant recipients. Eur. J. Clin. Microbiol. Infect. Dis. 1993, 12, 699-701.
38. 38 Cranage, M.P. and Gardner, P.S. Systemic cell-mediated and antibody responses in infants with respiratory syncytial virus infections. J. Med. Virol. 1980, 5, 161-170.
39. 39 Bertotto, A., Stagni, G., Caprino, D., Sonaglia, F. and Velardi, A. Cell-mediated immunity in RSV bronchiolitis. J. Pediatr. 1980, 97, 334-335.
40. 40 Mlinaric-Galinovic, G., Ugrcic, I., Cvetkovic, M., Pende, B. and Ivankovic, D. Rapid detection of respiratory syncytial virus in clinical specimens. Acta Virol. 1987, 31, 410-416.
41. 41 Welliver, R.C., Kaul, A. and Ogra, P.L. Cell-mediated immune response to respiratory syncytial virus infection: relationship to the development of reactive airway disease. J. Pediatr. 1979, 94, 370-375.
42. 42 Scott, R., Kaul, A., Scott, M., Chiba, Y. and Ogra, P.L. Development of in vitro correlates of cell-mediated immunity to respiratory syncytial virus infection in humans. J. Infect. Dis. 1978, 137, 810-817.
43. 43 Scott, R., Pullan, C.R., Scott, M. and McQuillin, J. Cell-mediated immunity in respiratory sycytial virus disease. J. Med. Virol. 1984, 13, 105-114.
44. 44 Welliver, R.C., Tristram, D.A., Batt, K., Sun, M., Hogerman, D. and Hildreth, S. Respiratory syncytial virus-specific cell-mediated immune responses after vaccination with a purified fusion protein subunit vaccine. J. Infect. Dis. 1994, 170, 425-428.
45. 45 Kim, H.W., Leikin, S.L., Arrobio, J., Brandt, C.D., Chanock, R.M. and Parrott, R.H. Cell-mediated immunity to respiratory syncytial virus induced by inactivated vaccine or by infection. Pediatr. Res. 1976, 10, 75-78.
46. 46 Waldman, R.H. and Ganguly, R. The role of the secretory immune system in protection against agents which infect the respiratory tract. Adv. Exp. Med. Biol. 1974, 45, 283-294.
47. 47 Anderson, L.J., Tsou, C. and Potter, C. et al. Cytokine response in respiratory syncytial virus stimulation of human peripheral blood mononuclear cells. J. Infect. Dis. 1994, 170, 1201-1208.
48. 48 Welliver, R.C., Wong, D.T., Sun, M. and McCarthy, N. Parainfluenza virus bronchiolitis. Epidemiology and pathogenesis. Am. J. Dis. Child. 1986, 140, 34-40.
49. 49 Lazar, A. and Wright, P.F. Cell-mediated immune response of human lymphocytes to influenza A/USSR (H1N1) virus infection. Infect. Immun. 1980, 27, 867-871.
50. 50 Lazar, A., Okabe, N. and Wright, P.F. Humoral and cellular immune responses of seronegative children vaccinated with a cold-adapted influenza A/HK/123/77 (H1N1) recombinant virus. Infect. Immun. 1980, 27, 862-866.
51. 51 Okabe, N., Hashimoto, G., Abo, T., Wright, P.F. and Karzon, D.T. Characterization of the human peripheral blood effector cells mediating antibody-dependent cell-mediated cytotoxicity against respiratory syncytial virus. Clin. Immunol. Immunopatho. 1983, 27, 200-209.
52. 52 Scott, R., de Landazuri, M.O., Gardner, P.S. and Owen, J.J. Human antibody-dependent cell-mediated cytotoxicity against target cells infected with respiratory syncytial virus. Clin. Exp. Immunol. 1977, 28, 19-26.
53. 53 Kaul, T.N., Welliver, R.C. and Ogra, P.L. Development of antibody-dependent cell-mediated cytotoxicity in the respiratory tract after natural infection with respiratory syncytial virus. Infect. Immun. 1982, 27, 492-498.
54. 54 Meguro, H., Kervina, M. and Wright, P.F. Antibody-dependent cell-mediated cytotoxicity against cells infected with respiratory syncytial virus: characterization of in vitro and in vivo properties. J. Immunol. 1979, 122, 2521-2526.
55. 55 Chiba, Y., Higashidate, Y., Suga, K., Honjo, K., Tsutsumi, H. and Ogra, P.L. Development of cell-mediated cytotoxic immunity to respiratory syncytial virus in human infants following naturally acquired infection. J. Med. Virol. 1989, 28, 133-139.
56. 56 Isaacs, D., Bangham, C.R. and McMichael, A.J. Cell-mediated cytotoxic response to respiratory syncytial virus in infants with bronchiolitis. Lancet 1987, 2, 769-771.
57. 57 Bangham, C.R., Openshaw, P.J., Ball, L.A., King, A.M., Wertz, G.W. and Askonas, B.A. Human and murine cytotoxic T cells specific to respiratory syncytial virus recognize the viral nucleoprotein (N), but not the major glycoprotein (G), expressed by vaccinia virus recombinants. J. Immunol. 1986, 137, 3973-3977.
58. 58 McMichael, A.J., Gotch, F.M., Dongworth, D.W., Clark, A. and Potter, C.W. Declining T-cell immunity to influenza, 1977-82. Lancet 1983, 2, 762-764.
59. 59 Hildreth, J.E., Gotch, F.M. and McMichael, A.J. Plasma membranes from influenza virus-infected cells induce in vitro human secondary virus-specific cytotoxic T lymphocyte responses. Molecular Bio. Med. 1983, 1, 225-233.
60. 60 McMichael, A.J., Michie, C.A., Gotch, F.M., Smith, G.L. and Moss, B. Recognition of influenza A virus nucleoprotein by human cytotoxic T lymphocytes. J. Gen. Virol. 1986, 67, 719-726.
61. 61 McMichael, A.J., Gotch, F.M., Noble, G.R. and Beare, P.A. Cytotoxic T-cell immunity to influenza. N. Engl. J. Med. 1983, 309, 13-17.
62. 62 Fries, L.F., Dillon, S.B. and Hildreth, J.E. et al. Safety and immunogenicity of a recombinant protein influenza A vaccine in adult human volunteers and protective efficacy against wild-type H1N1 virus challenge. J. Infect. Dis. 1993, 167, 593-601.
63. 63 Ennis, F.A., Rook, A.H. and Qi, Y.H. et al. HLA restricted virus-specific cytotoxic T-lymphocyte responses to live and inactivated influenza vaccines. Lancet 1981, 2, 887-891.
64. 64 McMichael, A.J., Gotch, F., Cullen, P., Askonas, B. and Webster, R.G. The human cytotoxic T cell response to influenza A vaccination. Clin. Exp. Immunol. 1981, 43, 276-284.
65. 65 de Sierra, T.M., Kumar, M.L., Wasser, T.E., Murphy, B.R. and Subbarao, E.K. Respiratory syncytial virus-specific immunoglobulins in preterm infants. J. Pediatr. 1993, 122, 787-791.
66. 66 Hall, C.B., Kopelman, A.E., Douglas, R.G. Jr., Geiman, J.M. and Meagher, M.P. Neonatal respiratory syncytial virus infection. N. Engl. J. Med. 1979, 300, 393-396.
67. 67 Chanock, R.M., Kapikian, A.Z., Mills, J., Kim, H.W. and Parrott, R.H. Influence of immunological factors in respiratory syncytial virus disease. Arch. Environ. Health 1970, 21, 347-355.
68. 68 Ogilvie, M.M., Vathenen, A.S., Radford, M., Codd, J. and Key, S. Maternal antibody and respiratory syncytial virus infection in infancy. J. Med. Virol. 1981, 7, 263-271.
69. 69 Parrott, R.H., Kim, H.W. and Arrobio, J.O. et al. Epidemiology of respiratory syncytial virus infection in Washington, D.C. II. Infection and disease with respect to age, immunologic status, race and sex. Am. J. Epidemol. 1973, 98, 289-300.
70. 70 Glezen, W.P., Paredes, A., Allison, J.E., Taber, L.H. and Frank, A.L. Risk of respiratory syncytial virus infection for infants from low-income families in relationship to age, sex, ethnic group and maternal antibody level. J. Pediatr. 1981, 98, 708-715.
71. 71 Glezen, W.P., Frank, A.L., Taber, L.H. and Kasel, J.A. Parainfluenza virus type 3: seasonality and risk of infection and reinfection in young children. J. Infect. Dis. 1984, 150, 851-857.
72. 72 Puck, J.M., Glezen, W.P. and Frank, A.L. et al. Protection of infants from infection with influenza A virus by transplacentally acquired antibody. J. Infect. Dis. 1980, 142, 844-849.
73. 73 Kasel, J.A., Walsh, E.E., Frank, A.L., Baxter, B.D., Taber, L.H. and Glezen, W.P. Relation of serum antibody to glycoproteins of respiratory syncytial virus with immunity to infection in children. Viral Immunol. 1987, 1, 199-205.
74. 74 Pullan, C.R., Toms, G.L., Martin, A.J., Gardner, P.S., Webb, J.K. and Appleton, D.R. Breast-feeding and respiratory syncytial virus infection. Br. Med. J. 1980, 281, 1034-1036.
75. 75 Toms, G.L., Gardner, P.S., Pullan, C.R., Scott, M. and Taylor, C. Secretion of respiratory syncytial virus inhibitors and antibody in human milk throughout lactation. J. Med. Virol. 1980, 5, 351-360.
76. 76 Scott, R., Scott, M. and Toms, G.L. Cellular and antibody response to respiratory syncytial (RS) virus in human colostrum, maternal blood and cord blood. J. Med. Virol. 1981, 8, 55-66.
77. 77 Tsutsumi, H., Honjo, T., Nagai, K., Chiba, Y., Chiba, S. and Tsugawa, S. Immunoglobulin A antibody response to respiratory syncytial virus structural proteins in colostrum and milk. J. Clin. Microbiol. 1989, 27, 1949-1951.
78. 78 Downham, M.A., Scott, R., Sims, D.G., Webb, J.K. and Gardner, P.S. Breast-feeding protects against respiratory syncytial virus infections. Br. Med. J. 1976, 2, 274-276.
79. 79 Taylor, G., Stott, E.J. and Bew, M. et al. Monoclonal antibodies protect against respiratory syncytial virus infection in mice. Immunology 1984, 52, 137-142.
80. 80 Walsh, E.E., Schlesinger, J.J. and Brandriss, M.W. Protection from respiratory syncytial virus infection in cotton rats by passive transfer of monoclonal antibodies. Infect. Immun. 1984, 43, 756-758.
81. 81 Prince, G.A., Hemming, V.G., Horswood, R.L. and Chanock, R.M. Immunoprophylaxis and immunotherapy of respiratory syncytial virus infection in the cotton rat. Virus Res. 1985, 3, 193-206.
82. 82 Crowe, J.E. Jr., Murphy, B.R., Chanock, R.M., Williamson, R.A., Barbas, C.F. and Burton, D.R. Recombinant human respiratory syncytial virus (RS) monoclonal antibody Fab is effective therapeutically when introduced directly into the lungs of RSV-infected mice. Proc. Natl. Acad. Sci. USA 1994, 91, 1386-1390.
83. 83 Prince, G.A., Horswood, R.L. and Chanock, R.M. Quantitative aspects of passive immunity to respiratory syncytial virus infection in infant cotton rats. J. Virol. 1985, 55, 517-520.
84. 84 Groothuis, J.R., Simoes, E.A. and Levin, M.J. et al. Prophylactic administration of respiratory syncytial virus immune globulin to high-risk infants and young children. The Respiratory Syncytial Virus Immune Globulin Study Group. N. Engl. J. Med. 1993, 329, 1524-1530.
85. 85 Rodriguez, W.J., Gruber, W.C. and Welliver, R.C. et al. Respiratory syncytial virus (RSV) immune globulin intravenous therapy for RSV lower respiratory tract infection in infants and young children at high risk for severe RSV infections. Respiratory Syncytial Virus Immune Globulin Study Group. Pediatrics 1997, 99, 454-461.
86. 86 Prince, G.A., Hemming, V.G., Horswood, R.L., Baron, P.A. and Chanock, R.M. Effectiveness of topically administered neutralizing antibodies in experimental immunotherapy of respiratory syncytial virus infection in cotton rats. J. Virol. 1987, 61, 1851-1854.
87. 87 Crowe, J.E. Jr., Bui, P.T., Siber, G.R., Elkins, W.R., Chanock, R.M. and Murphy, B.R. Cold-passaged, temperature-sensitive mutants of human respiratory syncytial virus (RSV) are highly attenuated, immunogenic and protective in seronegative chimpanzees, even when RSV antibodies are infused shortly before immunization. Vaccine 1995, 13, 847-855.
88. 88 Bell, D.Y., Haseman, J.A., Spock, A., McLennan, G. and Hook, G.E. Plasma proteins of the bronchoalveolar surface of the lungs of smokers and nonsmokers. Amer. Rev. Resp. Dis. 1981, 124, 72-79.
89. 89 Chanock, R.M., Kim, H.W. and Vargosko, A.J. Respiratory syncytial virus. I. Virus recovery and other observations during 1960 outbreak of bronchiolitis, pneumonia and minor respiratory diseases in children. JAMA 1961, 176, 647-653.
90. 90 Kaul, T.N., Welliver, R.C., Wong, D.T., Udwadia, R.A., Riddlesberger, K. and Ogra, P.L. Secretory antibody response to respiratory syncytial virus infection. Am. J. Dis. Child. 1981, 135, 1013-1016.
91. 91 McIntosh, K., Masters, H.B., Orr, I., Chao, R.K. and Barkin, R.M. The immunologic response to infection with respiratory syncytial virus in infants. J. Infect. Dis. 1978, 138, 24-32.
92. 92 Richardson, L.S., Yolken, R.H., Belshe, R.B., Camargo, E., Kim, H.W. and Chanock, R.M. Enzyme-linked immunosorbent assay for measurement of serological response to respiratory syncytial virus infection. Infect. Immun. 1978, 20, 660-664.
93. 93 Welliver, R.C., Kaul, T.N., Putnam, T.I., Sun, M., Riddlesberger, K. and Ogra, P.L. The antibody response to primary and secondary infection with respiratory syncytial virus: kinetics of class-specific responses. J. Pediatr. 1980, 96, 808-813.
94. 94 Yanagihara, R. and McIntosh, K. Secretory immunological response in infants and children to parainfluenza virus types 1 and 2. Infect. Immun. 1980, 30, 23-28.
95. 95 Murphy, B.R., Prince, G.A. and Walsh, E.E. et al. Dissociation between serum neutralizing and glycoprotein antibody responses of infants and children who received inactivated respiratory syncytial virus vaccine. J. Clin. Microbiol. 1986, 24, 197-202.
96. 96 Vainionpaa, R., Meurman, O. and Sarkkinen, H. Antibody response to respiratory syncytial virus structural proteins in children with acute respiratory syncytial virus infection. J. Virol. 1985, 53, 976-979.
97. 97 Ward, K.A., Lambden, P.R., Ogilvie, M.M. and Watt, P.J. Antibodies to respiratory syncytial virus polypeptides and their significance in human infection. J. Gen. Virol. 1983, 64, 1867-1876.
98. 98 Popow-Kraupp, T., Lakits, E., Kellner, G. and Kunz, C. Immunoglobulin-class-specific immune response to respiratory syncytial virus structural proteins in infants, children and adults. J. Med. Virol. 1989, 27, 215-223.
99. 99 Murphy, B.R., Graham, B.S. and Prince, G.A. et al. Serum and nasal-wash immunoglobulin G and A antibody response of infants and children to respiratory syncytial virus F and G glycoproteins following primary infection. J. Clin. Microbiol. 1986, 23, 1009-1014.
100. 100 Samson, A.C., Willcocks, M.M., Routledge, E.G., Morgan, L.A. and Toms, G.L. A neutralizing monoclonal antibody to respiratory syncytial virus which binds to both F1 and F2 components of the fusion protein. J. Gen. Virol. 1986, 67, 1479-1483.
101. 101 Murphy, B.R., Olmsted, R.A., Collins, P.L., Chanock, R.M. and Prince, G.A. Passive transfer of respiratory syncytial virus (RSV) antiserum suppresses the immune response to the RSV fusion (F) and large (G) glycoproteins expressed by recombinant vaccinia viruses. J. Virol. 1988, 62, 3907-3910.
102. 102 Murphy, B.R., Prince, G.A., Collins, P.L., Hildreth, S.W. and Paradiso, P.R. Effect of passive antibody on the immune response of cotton rats to purified F and G glycoproteins of respiratory syncytial virus (RSV). Vaccine 1991, 9, 185-189.
103. 103 Belshe, R.B., Van Voris, L.P. and Mufson, M.A. Parenteral administration of live respiratory syncytial virus vaccine: results of a field trial. J. Infect. Dis. 1982, 145, 311-319.
104. 104 Murphy, B.R., Collins, P.L., Lawrence, L., Zubak, J., Chanock, R.M. and Prince, G.A. Immunosuppression of the antibody response to respiratory syncytial virus (RSV) by pre-existing serum antibodies: partial prevention by topical infection of the respiratory tract with vaccinia virus-RSV recombinants. J. Gen. Virol. 1989, 70, 2185-2190.
105. 105 Yamazaki, H., Tsutsumi, H., Matsuda, K., Nagai, K., Ogra, P.L. and Chiba, S. Effect of maternal antibody on IgA antibody response in nasopharyngeal secretion in infants and children during primary respiratory syncytial virus infection. J. Gen. Virol. 1994, 75, 2115-2119.
106. 106 Tsutsumi, H., Matsuda, K., Yamazaki, H., Ogra, P.L. and Chiba, S. Different kinetics of antibody responses between IgA and IgG classes in nasopharyngeal secretion in infants and children during primary respiratory syncytial virus infection. Acta Pediatr. Jpn 1995, 37, 464-468.
107. 107 Hornsleth, A., Bech-Thomsen, N. and Friis, B. Detection of RS-virus IgG-subclass-specific antibodies: variation according to age in infants and small children and diagnostic value in RS-virus-infected small infants. J. Med. Virol. 1985, 16, 329-335.
108. 108 Wagner, D.K., Graham, B.S. and Wright, P.F. et al. Serum immunoglobulin G antibody subclass responses to respiratory syncytial virus F and G glycoproteins after primary infection. J. Clin. Microbiol. 1986, 24, 304-306.
109. 109 Watt, P.J., Zardis, M. and Lambden, P.R. Age related IgG subclass response to respiratory syncytial virus fusion protein in infected infants. Clin. Exp. Immunol. 1986, 64, 503-509.
110. 110 Julkunen, I., Hovi, T., Seppala, I. and Makela, O. Immunoglobulin G subclass antibody responses in influenza A and parainfluenza type 1 virus infections. Clin. Exp. Immunol. 1985, 60, 130-138.
111. 111 Wagner, D.K., Muelenaer, P. and Henderson, F.W. et al. Serum immunoglobulin G antibody subclass response to respiratory syncytial virus F and G glycoproteins after first, second and third infections. J. Clin. Microbiol. 1989, 27, 589-592.
112. 112 Wagner, D.K., Nelson, D.L., Walsh, E.E., Reimer, C.B., Henderson, F.W. and Murphy, B.R. Differential immunoglobulin G subclass antibody tilers to respiratory syncytial virus F and G glycoproteins in adults. J. Clin. Microbiol. 1987, 25, 748-750.
113. 113 Meurman, O., Waris, M. and Hedman, K. Immunoglobulin G antibody avidity in patients with respiratory syncytial virus infection. J. Clin. Microbiol. 1992, 30, 1479-1484.
114. 114 Welliver, R.C., Sun, M., Rinaldo, D. and Ogra, P.L. Respiratory syncytial virus-specific IgE responses following infection: evidence for a predominantly mucosal response. Pediatr. Res. 1985, 19, 420-424.
115. 115 Welliver, R.C., Sun, M., Hildreth, S.W., Arumugham, R. and Ogra, P.L. Respiratory syncytial virus-specific antibody responses in immunoglobulin A and E isotypes to the F and G proteins and to intact virus after natural infection. J. Clin. Microbiol. 1989, 27, 295-299.
116. 116 Russi, J.C., Delfraro, A., Borthagaray, M.D., Velazquez, B., Garcia-Barreno, B. and Hortal, M. Evaluation of immunoglobulin E-specific antibodies and viral antigens in nasopharyngeal secretions of children with respiratory syncytial virus infections. J. Clin. Microbiol. 1993, 31, 819-823.
117. 117 Yamazaki, H., Tsutsumi, H., Matsuda, K., Nagai, K., Ogra, P.L. and Chiba, S. Respiratory syncytial virus group-specific antibody response in nasopharyngeal secretions from infants and children after primary infection. Clin. Diagn. Lab. Immunol. 1994, 1, 469-472.
118. 118 Frank, A.L., Taber, L.H. and Wells, J.M. Individuals infected with two subtypes of influenza A virus in the same season. J. Infect. Dis. 1983, 147, 120-124.
119. 119 Wright, P.F., Thompson, J. and Karzon, D.T. Differing virulence of H1N1 and H3N2 influenza strains. Amer. J. Epidemiol. 1980, 112, 814-819.
120. 120 Steinhoff, M.C., Fries, L.F., Karron, R.A., Clements, M.L. and Murphy, B.R. Effect of heterosubtypic immunity on infection with attenuated influenza A virus vaccines in young children. J. Clin. Microbiol. 1993, 31, 836-838.
121. 121 Frank, A.L., Taber, L.H. and Glezen, W.P. et al. Reinfection with influenza A (H3N2) virus in young children and their families. J. Infect. Dis. 1979, 140, 829-836.
122. 122 Frank, A.L. and Taber, L.H. Variation in frequency of natural reinfection with influenza A viruses. J. Med. Virol. 1983, 12, 17-23.
123. 123 van Wyke Coelingh, K.L., Winter, C.C. and Tierney, E.L. et al. Antibody responses of human and nonhuman primates to individual antigenic sites of the hemagglutinin-neuraminidase and fusion glycoproteins after primary infection or reinfection with parainfluenza type 3 virus. J. Virol. 1990, 64, 3833-3843.
124. 124 van Wyke Coelingh, K.L., Winter, C.C., Tierney, E.L., London, W.T. and Murphy, B.R. Attenuation of bovine parainfluenza virus type 3 in nonhuman primates and its ability to confer immunity to human parainfluenza virus type 3 challenge. J. Infect. Dis. 1988, 157, 655-662.
125. 125 Belshe, R.B. and Hissom, F.K. Cold adaptation of parainfluenza virus type 3: induction of three phenotypic markers. J. Med. Virol. 1982, 10, 235-242.
126. 126 Belshe, R.B., Karron, R.A. and Newman, F.K. et al. Evaluation of a live attenuated, cold-adapted parainfluenza virus type 3 vaccine in children. J. Clin. Microbiol. 1992, 30, 2064-2070.
127. 127 Karron, R.A., Wright, P.F. and Hall, S.L. et al. A live attenuated bovine parainfluenza virus type 3 vaccine is safe, infectious, immunogenic and phenotypically stable in infants and children. J. Infect. Dis. 1995, 171, 1107-1114.
128. 128 Karron, R.A., Makhene, M., Gay, K., Wilson, M.H., Clements, M.L. and Murphy, B.R. Evaluation of a live attenuated bovine parainfluenza type 3 vaccine in a two-to six-month-old infants. Ped. Infect. Dis. J. 1996, 15, 650-654.
129. 129 Karron, R.A., Wright, P.F. and Newman, F.K. et al. A live human parainfluenza type 3 virus vaccine is attenuated and immunogenic in healthy infants and children. J. Infect. Dis. 1995, 172, 1445-1450.
130. 130 Feldman, S., Wright, P.F. and Webster, R.G. et al. Use of influenza A virus vaccines in seronegative children: live cold-adapted versus inactivated whole virus. J. Infect. Dis. 1985, 152, 1212-1218.
131. 131 Johnson, P.R., Feldman, S., Thompson, J.M., Mahoney, J.D. and Wright, P.F. Immunity to influenza A virus infection in young children: a comparison of natural infection, live cold-adapted vaccine, and inactivated vaccine. J. Infect. Dis. 1986, 154, 121-127.
132. 132 Steinhoff, M.C., Halsey, N.A. and Fries, L.F. et al. The A/Mallard/6750/78 avian-human, but not the A/Ann Arbor/ 6/60 cold-adapted, influenza A/Kawasaki/86 (H1N1) reassortant virus vaccine retains partial virulence for infants and children. J. Infect. Dis. 1991, 163, 1023-1028.
133. 133 Steinhoff, M.C., Halsey, N.A. and Wilson, M.H. et al. Comparison of live attenuated cold-adapted and avian-human influenza A/Bethesda/85 (H3N2) reassortant virus vaccines in infants and children. J. Infect. Dis. 1990, 162, 394-401.
134. 134 Anderson, E.L., Belshe, R.B., Burk, B., Bartram, J. and Maassab, H.F. Evaluation of cold-recombinant influenza A/Korea (CR-59) virus vaccine in infants. J. Clin. Microbiol. 1989, 27, 909-914.
135. 135 Swierkosz, E.M., Newman, F.K., Anderson, E.L., Nugent, S.L., Mills, G.B. and Belshe, R.B. Multidose, live attenuated, cold-recombinant, trivalent influenza vaccine in infants and young children. J. Infect. Dis. 1994, 169, 1121-1124.
136. 136 Belshe, R.B., Swierkosz, E.M., Anderson, E.L., Newman, F.K., Nugent, S.L. and Maassab, H.F. Immunization of infants and young children with live attenuated trivalent cold-recombinant influenza A H1N1, H3N2, and B vaccine. J. Infect. Dis. 1992, 165, 727-732.
137. 137 Piedra, P.A., Glezan, W.P. and Mbawuike, I. et al. Studies on reactogenicity and immunogenicity of attenuated bivalent cold recombinant influenza type A (CRA) and inactivated trivalent influenza virus (TI) vaccines in infants and young children. Vaccine 1993, 11, 718-724.
138. 138 Gruber, W.C., Darden, P.M. and Still, J.G. et al. Evaluation of bivalent live attenuated influenza A vaccines in children 2 months to 3 years of age: safety, immunogenicity and dose-response. Vaccine 1997, 15, 1379-1384.
139. 139 Gruber, W.C., Kirschner, K. and Tollefson, S. et al. Comparison of monovalent and trivalent live attenuated influenza vaccines in young children. J. Infect. Dis. 1993, 168, 53-60.
140. 140 Maassab, H.F. and DeBorde, D.C. Development and characterization of cold-adapted viruses for use as live virus vaccines. Vaccine 1985, 3, 355-369.
141. 141 Belshe, R.B., Van Voris, L.P., Bartram, J. and Crookshanks, F.K. Live attenuated influenza A virus vaccines in children: results of a field trial. J. Infect. Dis. 1984, 150, 834-840.
142. 142 Edwards, K.M., Dupont, W.D., Westrich, M.K., Plummer, W.D. Jr., Palmer, P.S. and Wright, P.F. A randomized controlled trial of cold-adapted and inactivated vaccines for the prevention of influenza A disease. J. Infect. Dis. 1994, 169, 68-76.
143. 143 Karron, R.A., Steinhoff, M.C. and Subbarao, E.K. et al. Safety and immunogenicity of a cold-adapted influenza A (H1N1) reassortant virus vaccine administered to infants less than six months of age. Ped. Infect. Dis. J. 1995, 14, 10-16.
144. 144 Clements, M.L., Makhene, M.K. and Karron, R.A. et al. Effective immunization with live attenuated influenza A virus can be achieved in early infancy. Pediatric Care Center. J. Infect. Dis. 1996, 173, 44-51.
145. 145 Hsu, K.H., Crowe, J.E. Jr. and Lubeck, M.D. et al. Isolation and characterization of a highly attenuated respiratory syncytial virus (RSV) vaccine candidate by mutagenesis of the incompletely attenuated RSV A2 ts-1 NG-1 mutant virus. Vaccine 1995, 13, 509-515.
146. 146 Crowe, J.E. Jr., Bui, P.T., Davis, A.R., Chanock, R.M. and Murphy, B.R. A further attenuated derivative of a cold-passaged temperature-sensitive mutant of human respiratory syncytial virus retains immunogenicity and protective efficacy against wild-type challenge in seronegative chimpanzees. Vaccine 1994, 12, 783-790.
147. 147 Crowe, J.E. Jr., Bui, P.T. and London, W.T. et al. Satisfactorily attenuated and protective mutants derived from a partially attenuated cold-passaged respiratory syncytial virus mutant by introduction of additional attenuating mutations during chemical mutagenesis. Vaccine 1994, 12, 691-699.
148. 148 Crowe, J.E. Jr., Bui, P.T. and Firestone, C.Y. et al. Live subgroup B respiratory syncytial virus vaccines that are attenuated, genetically stable, and immunogenic in rodents and nonhuman primates. J. Infect. Dis. 1996, 173, 829-839.
149. 149 Wright, P.F., Shinozaki, T., Fleet, W., Sell, S.H., Thompson, J. and Karzon, D.T. Evaluation of a live, attenuated respiratory syncytial virus vaccine in infants. J. Pediatr. 1976, 88, 931-936.